Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor	Not yet recruiting	Phase 2	2026-01-13		NCT07337447

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Federation Francophone de Cancerologie Digestive	19
Hospices Civils de Lyon	429

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Oscar Lambret	Lille	France	61
Centre Paul Strauss	Strasbourg	France	27
CHU Amiens Picardie	Amiens	France	31
CHU Avicenne APHP	Bobigny	France	1
CHU Caen Normandie	Caen	France	4
CHU de Bordeaux - Hôpital Haut-Leveque	Pessac	France	1
Chu de Grenoble	Grenoble	France	28
CHU de Poitiers	Poitiers	France	40
CHU Dijon	Dijon	France	37
CHU Montpellier - Hôpital Saint Eloi	Montpellier	France	2
CHU Rouen	Rouen	France	49
CHU Timone	Marseille	France	5
HEGP	Paris	France	4
Hôpital Beaujon	Clichy	France	16
Hôpital Henri Mondor	Créteil	France	27
Hôpital Robert Debré, CHU de Reims	Reims	France	1
Hôpital Saint Antoine APHP	Paris	France	2
Hôpital Saint Louis APHP	Paris	France	1
Institut Gustave Roussy	Villejuif	France	58
Institut Paoli Calmettes	Marseille	France	49
Service d'Oncologie Médicale - Hôpital Edouard Herriot - Hospices Civils de Lyon	Lyon	France	1

Clinical trials